Volume 10, Number 6—June 2004
Antimicrobial Resistance Incidence and Risk Factors among Helicobacter pylori–Infected Persons, United States
|Exposure||Odds ratio (95% CI)|
|Patient treated another time for infection
|Took Mylanta in last 12 mo
|New York, NY
|Palo Alto, CA
|Nashville, TN||0.4 (0.2–0.9)|
aN = 347; HARP, Helicobacter pylori Antimicrobial Resistance Monitoring Project; CI, confidence interval.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.